Skip to content

Effect of Unani drug in decrease sperm count

A Clinical Study on the efficacy of Kaunch in Oligospermia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031058
Enrollment
40
Registered
2021-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N461- Oligospermia

Interventions

Intervention1: Kaunch(Macuna Pruriens Linn.): The drug will be procured from the market and identified by FRLHT Bangalore. It will be prepared in the form of powder in the pharmacy of NIUM as per the

Sponsors

National Institute of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Infertile male patients. 2.Sperm count 3.Patients who were willing for a follow-up and semen examination. 4.Informed volunteers giving written consent. 5.No history of hepatic, renal disease, or any other chronic illness. 6.Normal liver and renal function tests.

Exclusion criteria

Exclusion criteria: 1.Patients below the age of 21 years and above 45 years. 2.Patients with azoospermia and aspermia. 3.Patients with genetic defects like cryptorchidism, Klinefelterâ??s syndrome. 4.Patients with diseases like varicocele, accessory sex gland infection, STD diseases. 5.The patient who does not report for follow up.

Design outcomes

Primary

MeasureTime frame
Semen analysis for sperm countTimepoint: 0th, 15th, 30th, 45th and 60 day

Secondary

MeasureTime frame
Quality of sexual life.Timepoint: 0th, 15th, 30th, 45th and 60 day

Countries

India

Contacts

Public ContactRahul Kumar

National Institute of Unani Medicine

dranzarnium@gmail.com9916164662

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026